Introdução: Estudos anteriores sugerem possível benefício do uso perioperatório das estatinas para redução de eventos cardiovasculares pósoperatórios. Metanálise previamente publicada demonstra que as estatinas reduzem mortalidade e infarto perioperatório em pacientes submetidos a cirurgia não-cardíaca. Entretanto, novas evidências em cirurgia cardíaca sugerem efeitos neutros ou mesmo deletérios das estatinas, sendo que metanálise recente demonstrou aumento da incidência de insuficiência renal aguda e tendência a maior mortalidade pós-operatória. Devido aos resultados conflitantes e escassez de evidências definitivas, foi realizada uma revisão sistemática e metanálise de estudos randomizados para avaliar os efeitos do uso perioperatório das estatinas em cirurgia cardíaca e nãocardíaca. Objetivo: Avaliar em pacientes adultos submetidos à cirurgia cardíaca e não-cardíaca a associação entre o uso perioperatório de estatinas e a incidência pós-operatória de infarto agudo do miocárdio, acidente vascular cerebral, insuficiência renal aguda e mortalidade. Metodologia: As bases de dados Pubmed, EMBASE e Cochrane foram avaliadas por 2 pesquisadores independentes até 1º de maio de 2018 para busca de artigos apropriados. Foram incluídos estudos randomizados que avaliaram o uso perioperatório de estatinas comparadas a placebo ou a nenhum tratamento em pacientes submetidos a cirurgia cardíaca e nãocardíaca. Foram calculados o risco relativo (RR) ou razão de chances (odds ratio, OR) e intervalo de confiança 95% (IC 95%) por meio de metanálise de efeitos fixos. Foi realizada a análise sequencial dos estudos (trial sequential analysis, TSA) para quantificar a confiabilidade estatística dos dados. A metodologia Cochrane foi utilizada. Os desfechos primários foram definidos como infarto agudo do miocárdio, acidente vascular cerebral, insuficiência renal aguda e mortalidade no período pós-operatório. Resultados: Foram incluídos 35 estudos randomizados totalizando 8200 pacientes. O uso de estatina comparado ao controle foi associado a menor incidência de infarto em pacientes submetidos a cirurgia não-cardíaca (OR=0,44 [IC 95%, 0,30 a 0,64], p < 0,0001), mas não em pacientes submetidos a cirurgia cardíaca (OR=0,93 [IC 95%, 0,70 a 1,24], p=0,61). O uso da estatina foi associado a maior incidência de insuficiência renal aguda em cirurgia cardíaca (RR=1,15 [IC 95%, 1,00 a 1,31], p=0,05), mas não em cirurgia não-cardíaca (RR=1,52 [IC 95%, 0,71 a 3,26], p=0,28). Não foi observado impacto do uso das estatinas na ocorrência de acidente vascular cerebral e mortalidade em ambos os grupos cirúrgicos. No entanto, a análise dos estudos com baixo risco de viés em cirurgia cardíaca demonstrou maior mortalidade com o uso de estatinas comparadas a placebo (OR=3,71 [IC 95%, 1,03 a 13,34], p=0,04). A análise sequencial dos estudos (TSA) não sugeriu conclusões definitivas sobre o assunto. Conclusão: As estatinas parecem ter efeito protetor contra infarto pós-operatório em cirurgia não-cardíaca, mas estão associadas a maior risco de insuficiência renal aguda em cirurgia cardíaca. Possíveis efeitos positivos ou negativos sobre a mortalidade não podem ser excluídos. Os dados dos estudos randomizados disponíveis até o momento ainda são insuficientes para conclusões definitivas sobre o uso perioperatório das estatinas. Estudos randomizados adicionais são necessários para avaliar o perfil de segurança e possíveis efeitos benéficos destas medicações nos desfechos pós-operatórios / Introduction: Previous studies supported potential beneficial effects of perioperative statin therapy to reduce postoperative complications. Accordingly, previous meta-analysis concluded that statin treatment decreases the perioperative incidence of mortality and myocardial infarction in non-cardiac surgery. In contrast, growing evidences on perioperative statins administration in cardiac surgery setting suggested neutral or even detrimental results. A recent systematic review and meta-analysis found that perioperative statin therapy in this population was associated with an increased incidence of postoperative acute kidney injury and a trend toward increased mortality. Due to the contrasting results and lack of definitive evidence, we performed a systematic review and meta-analysis of randomized controlled trials to examine the effects of perioperative statin therapy on postoperative outcomes in adult cardiac and non-cardiac surgery patients. Objective: To assess the association between perioperative statin therapy and postoperative myocardial infarction, stroke, acute kidney injury and mortality in patients submitted to cardiac and non-cardiac surgery. Methods: Pubmed, EMBASE, and Cochrane databases were searched through May 1st, 2018 for appropriate articles. Articles were independently assessed by 2 reviewers. Randomized controlled trials evaluating adult cardiac and non-cardiac surgery patients comparing perioperative statin therapy versus placebo or no treatment were included. Risk ratio (RR) or odds ratio (OR) and 95% confidence interval (CI) were obtained using fixedeffects meta-analyses. Trial sequential analysis (TSA) was performed to quantify the statistical reliability of data. The Cochrane methodology was used. Main outcomes were postoperative myocardial infarction, stroke, acute kidney injury, and mortality. Results: Data from 35 randomized controlled trials involving 8200 patients were included. Perioperative statin therapy was associated with lower incidence of postoperative myocardial infarction in noncardiac surgery compared to control (OR=0.44 [95% CI, 0.30 a 0.64], p < 0.0001), but not in cardiac surgery OR=0.93 [95% CI, 0.70 a 1.24], p=0.61). Higher incidence of acute kidney injury was evident in cardiac surgery patients receiving perioperative statins (RR=1.15 [95% CI, 1.00 a 1.31], p=0.05), but not in the non-cardiac surgery population (RR=1.52 [95% CI, 0.71 a 3.26], p=0.28). No difference in postoperative stroke and mortality was present in patients undergoing either cardiac or non-cardiac surgery. However, low risk of bias trials performed in cardiac surgery showed a higher mortality with statins versus placebo (OR=3.71 [95% CI, 1.03 a 13.34], p=0.04). Trial sequential analysis suggested no firm conclusions on the topic. Conclusions: Statins appear to be protective against postoperative myocardial infarction in non-cardiac surgery and associated with an increased risk of acute kidney injury in cardiac surgery. Possible positive or even negative effects on mortality could not be excluded. There is still insufficient randomized data for firm conclusions on perioperative statin therapy. Further randomized controlled trials should evaluate both the safety profile and possible effects on patients\' outcomes

Bakgrund: Sambandet mellan hjärtkirurgi med extracorporeal cirkulation (ECC) och blodtransfusion visar risker så som ökad morbiditet och mortalitet. Detta kan orsaka lidande för patienten och leda till kostnader för samhället. Att hantera och administrera blodprodukter är en omvårdnadshandling som sjuksköterskan ansvarar för och detta ställer därför krav på dennes kompetens.   Syftet: Syftet med denna studie var att studera intensivvårdssjuksköterskors kunskap om att ge blodtransfusion till patienter som genomgått hjärtkirurgi med ECC och om de ansåg sig ha kunskap om hur blodprodukter ska handhas och administreras på ett patientsäkert sätt, samt vilket behov av kompetensutveckling de ansåg sig ha.   Metod: Studien som utfördes hade en kvantitativ design med deskriptiv ansats. Ett icke-slumpmässigt urval gjordes på en Thoraxintensivvårdsavdelningen vid ett universitetssjukhus i Mellansverige och 30 intensivvårdssjuksköterskor inkluderades.   Resultat: Intensivvårdsjuksköterskorna hade en mycket låg till låg kunskap om de postoperativa komplikationer vid hjärtkirurgi med ECC som kan ha ett samband med blodtransfusion. Inget statistiskt signifikant samband kunde fastställas mellan intensivvårdsjuksköterskornas upplevda kunskap och faktiska kunskap om dessa postoperativa komplikationer. I resultatet sågs också att de önskade ytterligare utbildning.   Slutsats: Det fanns ett behov av vidare forskning inom området för att kunna uttala sig om intensivvårdssjuksköterskors kunskap och behov av ytterligare utbildning avseende risker med blodtransfusion till patienter som genomgått hjärtkirurgi med ECC. / Background: The relationship between cardiac surgery with extracorporeal circulation (ECC) and blood transfusion demonstrates risks like increased morbidity and mortality. This may cause suffering for the patient and further costs on society. To manage and administer blood products is a nursing act which the nurse is responsible for, and therefore it requires specific competence. Purpose: The purpose of this study was to study critical care nurses' knowledge of giving blood transfusion in patients undergoing cardiac surgery with ECC. Also if they felt they had knowledge of how blood products should be handled and administered safely for the patient, as well as the need for further education they felt they had.  Method: The study had a quantitative design with descriptive approach. A non - random selection was made on the Cardiothoracic Intensive Care Unit at an University Hospital in Sweden and 30 intensive care nurses were included.  Results: Intensive care nurses had a very low to low knowledge of the postoperative complications in cardiac surgery with ECC that may be related to blood transfusion. No statistically significant correlation could be established between critical care nurses' perceived knowledge and actual knowledge of these postoperative complications. In the result there was also possible to see that they wanted further education.   Conclusion: There was a need for further research in the area to give an opinion on critical care nurses' knowledge and the need for further education about the risks of blood transfusion in patients undergoing cardiac surgery with ECC.

La chirurgie cardiaque sous circulation extra-corporelle conduit à une altération de la perfusion de la microcirculation, qui peut contribuer de façon importante à la dysfonction d’organe postopératoire. Cette thèse rassemble des études cliniques et animales, dont le but était d’investiguer les mécanismes expliquant la dysfonction microcirculatoire en chirurgie cardiaque sous circulation extra-corporelle. En outre nous avons eu pour but d’évaluer deux stratégies thérapeutiques pour la préservation de la perfusion microcirculatoire au cours de la circulation extracorporelle : l’utilisation d’un flux pulsé comparativement à un flux non pulsé conventionnel durant la circulation extra-corporelle, et le traitement par imatinib dans le but de réduire la fuite vasculaire en inhibant la dysfonction de la barrière endothéliale. La thèse actuelle a démontré que la perfusion microcirculatoire est altérée durant et après la chirurgie cardiaque, et que ceci peut être attribué principalement à la dysfonction inflammatoire de la barrière endothéliale et à la fuite vasculaire conséquente. L’hémodilution concomitante en chirurgie cardiaque sous circulation extra-corporelle peut s’ajouter et contribuer également à la réduction de la perfusion microcirculatoire et de l’oxygénation. Nous avons montré que l’utilisation d’un flux pulsé durant la circulation extracorporelle améliore la perfusion microcirculatoire en postopératoire comparativement à un flux non-pulsé. Le traitement par imatinib a réduit la dysfonction de la barrière endothéliale et la fuite vasculaire dans notre modèle de circulation extracorporelle sur le rat et a permis de préserver la perfusion microcirculatoire et l’oxygénation durant et après la circulation extra-corporelle. En outre, le traitement par imatinib a permis de diminuer les marqueurs de souffrance rénale, pulmonaire et digestive après circulation extra-corporelle. A partir de nos résultats, la réduction de la fuite vasculaire et l’utilisation d’un flux pulsé durant la circulation extra-corporelle sont des interventions prometteuses pour la prévention des complications postopératoires chez les patients à risque de défaillance d’organe au décours de la chirurgie cardiaque sous circulation extra-corporelle. / Cardiac surgery with cardiopulmonary bypass leads to impaired perfusion of the microcirculation, which may be an important contributor to postoperative organ dysfunction. This thesis combines clinical and animal studies that aimed to investigate the mechanisms underlying microcirculatory dysfunction in cardiac surgery with cardiopulmonary bypass. Moreover, we aimed to evaluate two treatments strategies for preservation of microcirculatory perfusion during cardiopulmonary bypass : the use of pulsatile flow as compared to the conventional non pulsatile flow during cardiopulmonary bypass and treatment with imatinib in order to reduce vascular leakage by inhibiting endothelial barrier dysfunction.The current thesis has demonstrated that microcirculatory perfusion is impaired during and after cardiac surgery, and this can be attributed mainly to inflammatory endothelial barrier dysfunction and consequent vascular leakage. Concomitant hemodilution may additionally contribute to reduced microvascular perfusion and oxygenation in on-pumpcardiac surgery. We showed that the use of pulsatile flow during cardiopulmonary bypass improves postoperative microvascular perfusion as compared to non pulsatile flow. Imatinib treatment reduced endothelial barrier dysfunction and vascular leakage in our rat model for cardiopulmonary bypass and resulted in preservation of microcirculatory perfusion andoxygenation during and after extracorporeal circulation.Moreover, imatinib treatment resulted in reduced markers ofrenal, pulmonary and intestinal injury after cardiopulmonary bypass. Based on our findings, reduction of vascular leakage and use of pulsatile flow during cardiopulmonary bypass are promising interventions for the prevention of postoperative complications in patients at risk for organ failure following cardiac surgery with cardiopulmonary bypass.

Este estudo teve como objetivo desenvolver e validar micrométodo simples e sensível para quantificação de cefuroxima plasmática utilizando CLAE-UV com a finalidade de aplicação no monitoramento das concentrações de cefuroxima de pacientes submetidos à cirurgia de revascularização do miocárdio (RM) com CEC no esquema de doses administradas em bolus. Os tempos de retenção para o fármaco e padrão interno (guaifenesina) foram 5,3 e 8,7 minutos respectivamente, com um tempo de corrida de 15 minutos, utilizando coluna de fase reversa C18 (25 cmX4,6 mm, 5 micra) e fase móvel binária constituída de tampão acetato de amônio e trietilamina 0,025 M pH 4,2 e acetonitrila (80:20, v/v), fluxo de 1,0 mL/min, detecção no ultravioleta, &#955;=274nm em sistema isocrático de eluição. A validação deste método analítico investigada através dos limites de confiança apresentou sensibilidade de 0,1 &#181;g/mL (LD) e limite inferior de quantificação (LIQ) de 0,20 &#181;g/mL, linearidade na faixa compreendida 0,2 &#181;g/mL a 200 &#181;g/mL e 4,37% e 2,95% para precisão intra- e inter-dias, respectivamente. Boa exatidão (98,75%) e alta seletividade foram registradas para o método. Através de um protocolo de estudo para antibioticoprofilaxia das infecções cirúrgicas investigaram-se dez pacientes com indicação de cirurgia eletiva de revascularização do miocárdio com circulação extracorpórea. Realizou-se o monitoramento das concentrações plasmáticas após a dose de ataque de 1,5 g, seguido da manutenção realizada através de bolus em tres doses de 0,75 g 6/6 horas. Uma vez que as concentrações plasmáticas de cefuroxima obtidas na sexta hora (vale) foram inferiores à recomendada 16 &#181;g/mL (4x MIC), recomenda-se o aumento de 0,75 g 6/6 horas para 1,5 g mantendo-se o intervalo entre doses de forma a atingir aquela requerida na antibioticoprofilaxia das cirurugias cardíacas. / The objective of the study was to validate na analytical method to determine cefuroxime in plasma by high performance liquid chromatography (HPLC - UV) for clinical purposes in surgical patients submitted to elective cardiac surgery of myocardial revascularization with cardiopulmonary bypass after drug administration as IV boluses. Retention times for the analite and its internal standard (guaifenesin) were 5.3 and 8.7 minutes, respectively; run time was 15 minutes, using a reversed phase colunm C18 (250X4.6 mm, 5 micron) and a binary mobile phase of ammonium acetate/trietilamine 0.025 M pH 4.2 and acetonitrile (80:20, v/v), flow rate 1 mL/min, ultraviolet detector, &#955;=274nm isocratic elution system. Validation of confidence limits presented 0.1 &#181;g/mL sensitivity (LD) and lower limit of quantification (LLOQ) of 0.20 &#181;g/mL, linearity in the range 0.2 &#181;g/mL to 200 &#181;g/mL and 4.37% e 2.95% for intra- / interday precisions, respectively. Good accuracy (98.75%) and high selectivity were obtained. The study protocol for antibiotic prophylaxis of surgical infections was designed for ten patients with indication of elective cardiac surgery of myocardial revascularization with cardiopulmonary bypass. Loading dose of 1.5 g followed by maintenance dose of 0.75 g every six hours by IV boluses were applied and plasma drug monitoring was done. Based on data obtained cefuroxime plasma concentrations at time dose interval were lower than 16 &#181;g/mL (4x MIC) at the trough, consequently it is recommended to increase the maintainance dose from 0.75 g 6/6 h up to 1.5 g 6/6h, to reach the minimum required for the antibiotic prophylaxis of cardiac surgeries.

Delirium é um estado confusional agudo caracterizado por um distúrbio de consciência, alteração na cognição e curso flutuante ao longo do dia. É a complicação mais comum observada em idosos hospitalizados. É freqüente no pós-operatório de cirurgia cardíaca, e pode chegar a taxas tão altas quanto 73% em pacientes mais idosos. Pacientes com delirium apresentam maior risco de morte, demência e institucionalização, aumento do tempo de internação hospitalar e dos custos. Os objetivos deste estudo foram: 1) determinar a incidência do delirium no pós-operatório de cirurgia cardíaca em idosos; 2) identificar fatores predisponentes e precipitantes neste contexto; 3) avaliar a relação entre delirium e morbimortalidade por até 18 meses de seguimento. Este estudo foi observacional, prospectivo, tipo coorte, realizado no Hospital de Messejana no período de Setembro/2011 à Dezembro/2013. Foram estudados 173 pacientes com idade > 60 anos. Antes da cirurgia, os pacientes foram avaliados quanto à função cognitiva através do MEEM e TFV, e pelo CAM, para determinar a presença de delirium pré-operatório, motivo de exclusão do estudo. Foram registradas variáveis referentes aos dados demográficos, doenças prévias, medicações utilizadas, e calculado o risco de mortalidade cirúrgica para cada paciente através do EuroSCORE II. Resultados de exames pré-operatórios como ECG, ecodopplercardiograma, cateterismo cardíaco, Doppler de carótidas e exames laboratoriais também foram registrados. Durante a cirurgia, as variáveis avaliadas foram o tempo de CEC e clampeamento de aorta, duração da cirurgia e anestesia e uso de hemoderivados. Como variáveis pós-operatórias foram analisados o TIOT, tempo de permanência na UTI, presença de disfunção renal, hipoxemia. O delirium foi avaliado pelo CAM-ICU no pós-operatório. Para o desfecho composto foram registrados óbitos por todas as causas, infecções e IAM perioperatório identificados até a alta hospitalar ou 30 dias após a cirurgia. Os pacientes foram seguidos por um período de 12 a 18 meses e registrados eventos como óbitos, reinternações e demência, através de nova avaliação com MEEM e TFV. Após análise univariada foi realizada análise multivariada por regressão logística múltipla para identificar as variáveis independentes. A idade média dos pacientes foi 69,5 + 5,8. Cerca de 75,14% eram hipertensos e 39,88% eram diabéticos. A média do EuroSCORE II foi 4,06 + 3,86. Cerca de 30,06% eram analfabetos. A média do grau de escolaridade foi 3,05 + 3,08 anos. A incidência do delirium foi 34,1%. Em 70% dos casos, o delirium foi detectado nos dois primeiros dias após a cirurgia. Foram identificados o grau de escolaridade (OR = 0,81; IC 95% 0,71 - 0,92; p=0,002), HAS (OR = 2,73; IC 95% 1,16 - 6,40; p=0,021) e a presença de valvopatia mitral ( OR = 2,93; IC 95% 1,32 - 6,50; p=0,008) como fatores predisponentes independentes para delirium. Como fator precipitante independente foi identificado o tempo de internação na UTI com OR=1,18; IC 95% 1,07 - 1,30 e p=0,001. O delirium foi fator de risco independente para o desfecho composto com OR=2,35; IC 95% 1,20 - 4,58 e p=0,012, além do TIOT > 900 minutos (OR=2,50; IC 95% 1,30 - 4,80; p=0,006) após análise multivariada. Não houve relação entre delirium e óbito após alta hospitalar, demência ou taxa de reinternação durante o seguimento / Delirium is an acute and transient syndrome with features of inattention and global cognitive dysfunction over the time. Among elderly hospitalized patients is the most common complication. The postoperative cardiac surgery delirium occurs in 73% in older patients. Delirium patients, have prominent risk factors for dementia, institutionalization, death, hospital care and increased cost of healthcare. The aims of this study were: 1) to determine the incidence of postoperative cardiac delirium, focusing particularly on elderly individuals; 2) to identify the predisposing and precipitating factors of delirium; 3) evaluate the morbi-mortality associated with delirium in a follow up of eighteen months. A prospective observational cohort study (n=173) patients, aged >= 60 years, admitted at Heart and Lung Messejana\'s Hospital between September/2011 to December/2013. Before the surgery, the Mini-Mental Status Examination (MMSE) and Verbal Fluency Test (VFT) were administered to assess patient\'s cognitive functioning. The patients were screened for delirium using the Confusion Assessment Method (CAM). Patients were excluded preoperatively if they met criteria for delirium. Variables related to demographic data, previous diseases, medications were recorded and EuroSCORE II calculated the risk of surgical mortality for each patient. Results of preoperative tests, like ECG, echocardiography, cardiac catheterization, carotid Doppler ultrassound and laboratory tests were also recorded. During the surgery, variables were ECC (extracorporeal circulation) and aortic clamping time, duration of surgery and anesthesia, and blood products were also recorded. Postoperative variables analyzed were: the orotracheal intubation time (OIT), length of stay in the ICU, renal dysfunction and hypoxemia. The postoperative delirium was accessed by CAM-ICU. Mortality from any cause, infection and perioperative myocardial infarction, identified until hospital discharge or 30 days after surgery were predefined as the composite endpoint. During a follow up of 12 to 18 months, a new assessment using MMSE and VFT were held; events such as, deaths, readmissions and dementia were recorded. Multivariate analysis was performed by multiple logistic regressions to identify independent variables. Patients aged 69.5 ± 5.8. About 75.14% were hypertensive; 39.88% were diabetic. The mean EuroSCORE II was 4.06±3.86. About 30.06% were illiterate; an average 3.05 ± 3.08 years of school. In 70% of cases, delirium was detected at the first two days after surgery with an incidence of 34.1%. The degree of literacy (OR = 0,81; 95% CI 0,71 - 0,92; p=0,002), hypertension (OR = 2,73; 95% CI 1,16 - 6,40; p=0,021) and mitral valve disease (OR = 2,93; 95% CI 1,32 - 6,50; p=0,008) were independently associated with delirium. Longer ICU length of stay (OR=1,18; 95% CI 1,07 - 1,30; p=0,001) was also independently associated with delirium as a precipitation factor. Delirium was an independent risk factor for the composite outcome (OR = 2.35; 95% CI 1.20 - 4.58 and p = 0.012); OIT > 900 minutes (OR = 2.50; 95% CI 1.30 - 4.80; p = 0.006) after multivariate analysis. There was no relationship between delirium and mortality after hospital discharge, as well as, dementia or hospital readmission during follow up

Introdução: A disfunção respiratória é uma das complicações de maior prevalência no período pós-operatório de pacientes submetidos à cirurgia de revascularização do miocárdio (RM) com circulação extracorpórea (CEC), mesmo na ausência de doença pulmonar prévia1. Por meio de tomografia computadorizada, foram investigadas as alterações pulmonares pósoperatórias e o seu impacto na oxigenação. Métodos: vinte pacientes não hipoxêmicos em programação de cirurgia eletiva de revascularização do miocárdio com CEC foram estudados. Medidas hemodinâmicas, e amostras sanguíneas seriadas foram obtidas antes da cirurgia, após a intubação orotraqueal, após a CEC, na UTI, 12h, 24h e 48h após a cirurgia. Tomografias volumétricas pré e pós-operatórias foram adquiridas em condições de apneia após uma expiração espontânea. Os dados foram analisados usando teste de t Student; o comportamento temporal dos dados hemodinâmicos e outras variáveis fisiológicas foi analisado ao longo do tempo, usando análise de variância de uma via para repetidas medidas, seguido pelo teste de Student-Neumann-Keuls, quando necessário.Resultados: a relação PaO2/FiO2 diminuiu de forma significativa após a indução da anestesia, atingindo o seu nadir após a saída de CEC. Comparando-se com a TC pré-operatória, foi observada uma redução de 31% no volume de gás pulmonar (p<0,001), ao passo que foi observado um aumento do volume de tecido de 19% (p<0,001). A área não aerada dos pulmões aumentou de 253 97 g(p < 0.001), de 3 % a 27 %, após a cirurgia; e a área pobremente aerada pulmonar apresentou aumento de 72 68 g (p < 0.001), de 24 % to 27 %, enquanto a área normalmente aerada pulmonar reduziu de 147 119 g (p < 0.001), que representa 72 % to 46%. Não foram observadas correlações entre a relação PO2/FIO2 ou na fração de shunt nas primeiras 24 horas pós-operatórias Conclusões: A estrutura pulmonar está profundamente modificada após a cirurgia de RM com CEC. Associadas a outros fatores, essas alterações são responsáveis pela ocorrência de hipoxemia resultantes de atelectasias / Introduction: Hypoxemia is a frequent complication after coronary artery bypass graft (CABG) with cardiopulmonary bypass (CPB), usually attributed to atelectasis. Using computed tomography (CT), we investigated pulmonary alterations postoperatively and its impact on oxygenation. Methods: Twenty non-hypoxemic patients with normal cardiac function scheduled to CABG under CPB were studied. Hemodynamic measurements and blood samples were obtained before surgery, after intubation, after CPB, at ICU admission, 12h, 24h and 48h after surgery. Pre and postoperative volumetric thoracic CT scans were acquired in apnea conditions after a spontaneous expiration. Data was analyzed using paired Student t test and two-way repeated measures analysis of variance followed by SNK test when indicated. Results: PaO2/FiO2 ratio was significantly reduced after anesthesia induction, reaching its nadir after CPB and partially ameliorating 12h after surgery. Compared to preoperative CT, there was a postoperative 31 % reduction in pulmonary gas volume (p < 0.001) while tissue volume increased by 19 % (p < 0.001). Non-aerated lung increased by 253 97 g(p < 0.001), from 3 % to 27 %, after surgery and poorly-aerated lung by 72 68 g (p < 0.001), from 24 % to 27 % while normally-aerated lung was reduced by 147 119 g (p < 0.001), from 72 % to 46 %. No correlations were observed between PaO2/FiO2 ratio or shunt fraction at 24 h postoperatively and postoperative lung alterations. Conclusions: Lung structure is profoundly modified after CABG with CPB. Taken together, these multiple alterations occurring in the lungs are responsible for postoperative hypoxemia instead of atelectasis alone

No description available.

Introdução: O ângulo de fase (AF), derivado da análise de bioimpedância elétrica (BIA), tem sido interpretado como indicador de integridade da membrana celular; e a dinamometria manual têm sido usados como indicadores de prognóstico em algumas situações clínicas. Objetivos: avaliar o comportamento do AF e da dinamometria manual em pacientes submetidos à cirurgia cardíaca e associá-los com EuroSCORE e desfechos clínicos. Métodos: Estudo de coorte prospectivo com 50 pacientes submetidos à cirurgia cardíaca, com idade ≥18 anos, entre janeiro de 2015 e outubro de 2015. O AF e a dinamometria manual foram aferidos em três momentos: pré-operatório, pré-alta hospitalar e três meses após à cirurgia. Também foram coletadas as seguintes variáveis: tempo de circulação extracorpórea (CEC), isquemia, ventilação mecânica (VM), tempo de internação na Unidade de Terapia Intensiva (UTI) e tempo de internação hospitalar após à cirurgia e foi calculado o EuroSCORE. Resultados: Os pacientes foram de predominância do sexo masculino 32 (64%) com idade média de 62,8 ± 10,2 anos, tempo de estadia na UTI de 3 dias (2 – 23), tempo de internação pré-operatória de 7 (5 – 61) dias e EuroSCORE 4 (0 – 10) dias. Houve redução do AF, com diferença entre o período pré-operatório e os dois momentos de avaliação no pós-operatório (p<0,001). Quando a dinamometria manual foi avaliada ao longo do tempo foi observada uma redução entre o préoperatório e a pré-alta hospitalar (p<0,001) e recuperação dessa nos três meses após à cirurgia (p<0,001). A VM e o EuroSCORE tiveram correlação inversa com o AF e a dinamometria manual nos três momentos. A correlação do AF no período pré-operatório do EuroScore p=0,007 e o segundo e o terceiro momento p<0,001, e para os três momentos da VM (p<0,001), respectivamente. Já a correlação da dinamometria manual no primeiro e no segundo momento com o EuroSCORE e a VM p <0,001 e no terceiro momento p=0,010 e p=0,018, respectivamente. Conclusões: O AF e a dinamometria manual parecem estar associados ao tempo de VM, tempo de internação na UTI e tempo de internação no pós-operatório em pacientes submetidos à cirurgia cardíaca. / Background and aims: The phase angle (PA), derived from bioelectrical impedance analysis (BIA), have been interpreted as cell membrane integrity indicator; and the handgrip strength (HGS) have been used as prognostic indicators in some clinical situations. This study aims to evaluate the PA and HGS behavior in patients undergoing cardiac surgery and associate these with clinical outcomes and prognostic. Methods: Cohort prospective study of consecutive recruited patients undergoing cardiac surgery aged ≥18 years. The PA and HGS were measured at three set points: preoperatively, hospital predischarge and three months after surgery. Were also collected: time of cardiopulmonary bypass (CPB), ischemia, mechanical ventilation (MV), length of stay (LOS) in Intensive Care Unit (ICU) and LOS after surgery and calculated the EuroSCORE. Results: A decrease in PA was observed between the preoperative and the two postoperative stages (p<0.001). When the HGS was evaluated over time was seen a reduction between preoperative and predischarge (p<0.001) and a recovery in three months after surgery (p<0.001). The MV and EuroSCORE had an inverse association with PA and HGS in three stages. PA correlation in the first stage of the EuroSCORE p=0.007 and the second and third stage p<0.001, and for the three stages of MV (p<0.001), respectively. In HGS correlation in the first and second stage of the EuroSCORE and MV p<0,001 and in the third stage p=0.010 and p=0.018, respectively. Conclusion: PA and HGS appears to be related to MV time, LOS in ICU and LOS after surgery in patients undergoing cardiac surgery.

L’insuffisance rénale aiguë (IRA) représente une complication fréquente de lachirurgie cardiaque pédiatrique sous circulation extracorporelle (CEC). Son traitement resteessentiellement conservateur, visant à prévenir l’aggravation de l’atteinte rénale, ousubstitutif, par épuration extrarénale (EER). L’EER précoce améliore le pronostic des adultesen défaillance multiviscérale, mais ceci n’a pas été montré chez l’enfant après chirurgiecardiaque. Le diagnostic de l’IRA repose actuellement sur une diminution du débit defiltration glomérulaire (DFG), reflété par la hausse de la créatinine sérique (sCr), et laréduction de la diurèse. Ces critères traduisent une perte de la fonction glomérulaire ; orl’atteinte initiale dans l’IRA post-chirurgicale se situe au niveau tubulaire. Ces critères sontpeu spécifiques et tardifs, et risquent de retarder le diagnostic et la prise en charge de l’IRA.Des nouveaux biomarqueurs rénaux, traduisant la présence d’une lésion tubulaire, dont leNeutrophil Gelatinase-Associated Lipocaline urinaire (NGALu) est le plus populaire,permettraient un diagnostic plus précoce.Objectif. L’objectif de ce travail est triple : (i) explorer l’association entre le délai de la miseen route de l’EER et le pronostic à court et moyen terme chez le patient < 1an qui développeune IRA post-chirurgie cardiaque ; (ii) explorer les performances diagnostiques desvariations précoces de la sCr pour l’IRA sévère ; et (iii) explorer les performancesdiagnostiques de l’élévation de NGALu pour l’IRA sévère dans des populations similaires depatients < 1an.Méthode. Une cohorte monocentrique rétrospective de patients < 1an constituée sur 10 ansa servi pour étudier l’association entre le délai de la mise en route de l’EER et la survie àcourt et moyen terme. La technique de pondération inverse par le score de propension a étéutilisée afin de réduire le biais associé aux changements des pratiques inhérents à la longuepériode d’inclusion. Une deuxième cohorte monocentrique rétrospective de patients < 1anconstituée sur 3 ½ ans a servi pour étudier les performances diagnostiques des variationsprécoces de la sCr pour l’IRA sévère. Enfin, une troisième cohorte monocentriqueprospective de patients < 1an constituée sur 18 mois a servi pour étudier les performancesdiagnostiques de NGALu pour l’IRA sévère. Pour l’étude des deux biomarqueurs, sCr etNGALu, la méthodologie utilisée a été similaire : partition des trajectoires individuelles devariation, puis analyse de l’association avec un critère composite (recours à l’EER et/oudécès postopératoire) et définition du profil à faible risque d’IRA; enfin, utilisation de laméthodologie des courbes ROC et des tables de reclassification pour quantifier leursperformances diagnostiques respectives.Résultats. La mise en route de l’EER le jour de la chirurgie ou le lendemain a été associéeavec une augmentation d’environ 45% de la survie à 30 et 90 jours. La variation de la sCrdans les 2 jours suivant la chirurgie a été spécifique mais peu sensible et peu discriminantepour le diagnostic de l’IRA sévère ; le profil à faible risque, rencontré chez près de 50% despatients a été une diminution durable d’environ 25% de la sCr par rapport à la valeur basale.NGALu a été discriminant et prédictif pour le critère composite ; la concentration de NGALu aaugmenté dans les 2 heures suivant la chirurgie, et est restée élevée chez les patientsprésentant le critère composite.Discussion et conclusions. Si la prise en charge précoce par EER de l’IRA sévère est unepriorité en termes de pronostic chez le patient < 1an, alors il faut se munir de moyensdiagnostiques précoces et performants. La variation précoce de la sCr est peu sensible etpeu discriminante. En revanche, l’élévation précoce de l’NGALu présente d’excellentesperformances diagnostiques pour l’IRA sévère, faisant de NGALu un marqueur rénalprometteur dans la population < 1an bénéficiant d’une chirurgie cardiaque. / Acute kidney injury (AKI) is common following congenital cardiac surgery withcardiopulmonary bypass (CPB). To date, no prophylactic intervention has proved to beuseful for the prevention of postoperative AKI. When AKI occurs, treatment is mainlysupportive and, when severe, requires renal replacement therapy (RRT). Several reportshave shown better outcome with early RRT in adults with multiorgan failure. No such data isavailable in children undergoing cardiac surgery, and criteria for RRT vary among centres.The definition of AKI is a reduction in the glomerular filtration rate (GFR), and the diagnosis isbased on an increase in serum creatinine (sCr) and a reduction in urine output; these arefunctional criteria, translating the consequences of glomerular injury. However, it iscommonly admitted that the first pathophysiologic finding in AKI following cardiac surgery istubular injury. Besides, the functional criteria are late, are not specific, and may delay thediagnosis of AKI. Novel AKI biomarkers, specific of tubular injury are available nowadays,with urine Neutrophil Gelatinase-Associated Lipocaline (uNGAL) being the most popular –they may allow for an early diagnosis of AKI.Objectifs. The aim of this work was: (i) explore associations between the delay to RRT, earlyand mid-term outcome in patients younger than 1 year of age who develop AKI followingcardiac surgery; (ii) assess the accuracy of early sCr variations and (iii) of uNGAL for severeAKI in two similar populations aged < 1 year.Methods. A single centre retrospective cohort of patients aged < 1 year undergoing surgeryover 10 years was used to asses the association between the delay to RRT et short and midtermsurvival. Inverse probability of treatment weighting was used to reduce bias due tochanges in practices that occurred during the long study period. A second retrospectivecohort of patients aged < 1 year undergoing surgery over 3 ½ years was used to asses theaccuracy of early sCr variations for the diagnosis of severe AKI. Finally, a third prospectivecohort of patients aged < 1 year undergoing surgery over 18 month was used to asses theaccuracy of uNGAL for the diagnosis of severe AKI. The study of both sCr and uNGAL useda similar methodology: first clustering of all individual trajectories of variation, enablingassessment of the association with a composite outcome (need for RRT and/or death) andidentification of the « normally expected » postoperative evolution of both sCr an uNGAL,associated with the best outcome; second, use of ROC curves and reclassification tables toassess the accuracy of each biomarker for the diagnosis of AKI.Results. Early RRT, initiated on the day of surgery or on day 1 following surgery, wasassociated with a 45% increase in 30-days and 90-days survival. Early sCr variation, within 2days of surgery, had a good specificity but was lacking sensitivity and discrimination for thediagnosis of severe AKI; the « expected » sCr evolution was a persistent 25% postoperativereduction relative to baseline. uNGAL had good discrimination and predictive ability for thecomposite outcome; uNGAL concentration increased within 2 hours of surgery, andremained high in patients with the composite outcome.Discussion and conclusions. If early RRT improves outcome in patients aged < 1 yearswith AKI following cardiac surgery, then it becomes important to perform an early diagnosisof severe AKI. To date, diagnosis of AKI is based on early sCr variations, but such variationslack sensitivity and discrimination for the diagnosis of severe AK. On the other hand, theincrease in uNGAL within hours of surgery has excellent accuracy for the diagnosis of severeAKI, making uNGAL a promising AKI biomarker in patients aged < 1 year undergoing cardiacsurgery with cardiopulmonary bypass.

Introdução e Objetivos: A circulação extracorpórea (CEC) pode alterar a cinética de fármacos, inclusive dos antibióticos. O objetivo deste estudo foi avaliar influência da CEC sobre a farmacocinética da cefuroxima e verificar se o esquema posológico proposto: 1, 5g em bolus, seguido por três bolus de 750 mg 6/6 horas por 24 horas, mantém concentrações plasmáticas adequadas em pacientes submetidos à revascularização do miocárdio (RM). Método: Foi realizado estudo prospectivo observacional com grupo controle comparando 10 pacientes submetidos à RM com CEC e 9 pacientes submetidos à RM sem CEC (Registro Clincal trials: NCT0122882). Amostras sanguineas foram coletadas sequencialmente após cada dose de antibiótico e analisadas por meio do método de cromatografia líquida de alta pressão (HPLC). Análise de variância (ANOVA) foi utilizada para a comparação das concentrações plasmáticas e Log-rank para comparar as curvas que avaliaram o tempo, após a administração da cefuroxima, para que fossem atingidas concentrações abaixo de 16 g/mL (quatro vezes a MIC- mínima inhibitory concentration); considerando p< 0,05. Resultados: A CEC com tempo médio de 59,7 min 21,1 minutos não alterou a farmacocinética ou as concentrações plasmáticas da cefuroxima. O clearance médio dp (mL/ Kg/ min) e a mediana da concentração mínima (mg/ dL) do grupo RM com CEC versus RM sem CEC foram 1,7 0,7 versus 1,6 0,6 (p= 0,67) e 6,1 versus 5,7 (p= 0,77), respectivamente. Ambos os grupos apresentaram diminuição nas concentrações plasmáticas influenciadas somente pelo tempo, após cada bolus de cefuroxima (p< 0,001). Concentrações acima de quatro vezes a MIC foram mantidas por três horas, por todos os pacientes, porém, após seis horas do primeiro bolus a probabilidade de manutenção das mesmas concentrações foi de 0,2 para o grupo RM com CEC e de 0,44 para o grupo RM sem CEC, p= 0,867. Após os demais bolus concentrações abaixo de 16 g/mL foram atingidas antes de três horas. Conclusão: A CEC não influenciou as concentrações plasmáticas ou a farmacocinética da cefuroxima. Os resultados da farmacocinética devem ser considerados para a escolha de um melhor esquema posológico / Background and Objectives: Cardiopulmonary bypass (CPB) can alter the kinetic of drugs, including antibiotics. The aim of this study was evaluation of the CPB influence on the plasma concentrations and pharmacokinetics of cefuroxime and assess whether the dosing regimen 1.5 g dose, followed by 750 mg 6/6h for 24h is adequate for antibiotic prophylaxis. Methods: A prospective controlled observational study compared 10 patients undergoing surgery with CPB and 9 submitted to off-pump surgery, (Clinical trials identifier: NCT0122882). After each cefuroxime dose, blood samples were sequentially collected and analyzed using high-efficiency chromatography (HPLC). Plasma concentrations were compared using variance analysis and log-rank test was employed to evaluate the differences between curves that quantified the fraction of patients with a remaining plasma concentration above 16 mg/L within 6 h after each bolus; considering P < 0.05 significant. Results: After each cefuroxime bolus, both groups presented a significant decrease in plasma concentration over time (p< 0.001). Mean CPB time of 59.7 ± 21.1 min did not change cefuroxime pharmacokinetics or plasma concentrations. The mean clearance ± SD (mL/kg/min) and median of minimum concentration (mg/dL) of the CPB group versus the off-pump group were 1.7 ± 0.7 versus 1.6 ± 0.6 (p= 0.67) and 6.1 versus 5.7 (p= 0.77), respectively. Up to 3 h, but not after 6 h, following the first bolus, all patients had plasma concentrations above 16 mg/L (CPB group= 0.2 and off-pump group= 0.44, p=0.867). After another bolus, concentrations below 16 mg/dL were reached before 3 h. Conclusions: CPB does not influence cefuroxime plasma concentration, but pharmacokinetic data should be considered when choosing intervals between doses